0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. Dogs of 20.0-22.7 kg take half a 3.6 mg plus half a 16 mg tablet (or two 5.4 mg tablets). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
· twice daily for up to 14 days, then once daily
twice daily for up to 14 days, then once daily
GeorgiaYes, veterinary
Veterinary (National Food Agency)
In the register: აპოქუელი 3.6მგ შემოგარსული ტაბლეტები ძაღლებისთვის
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. Dogs of 20.0-22.7 kg take half a 3.6 mg plus half a 16 mg tablet (or two 5.4 mg tablets). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
· twice daily for up to 14 days, then once daily
twice daily for up to 14 days, then once daily
GeorgiaYes, veterinary
Veterinary (National Food Agency)
In the register: აპოქუელი 3.6მგ შემოგარსული ტაბლეტები ძაღლებისთვის
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. Dogs of 20.0-22.7 kg take half a 3.6 mg plus half a 16 mg tablet (or two 5.4 mg tablets). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
Dog
3–4.4 kg
By mouth
twice daily for up to 14 days, then once daily
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Apoquel 3.6 mg, 5.4 mg and 16 mg film-coated tablets for dogs - Summary of Product Characteristics
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. Dogs of 20.0-22.7 kg take half a 3.6 mg plus half a 16 mg tablet (or two 5.4 mg tablets). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
Dog
6–8.9 kg
By mouth
twice daily for up to 14 days, then once daily
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Apoquel 3.6 mg, 5.4 mg and 16 mg film-coated tablets for dogs - Summary of Product Characteristics
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. For 22.8-26.7 kg the label also allows half a 5.4 mg plus half a 16 mg tablet. Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
· twice daily for up to 14 days, then once daily
twice daily for up to 14 days, then once daily
GeorgiaYes, veterinary
Veterinary (National Food Agency)
In the register: აპოქუელი 5.4მგ შემოგარსული ტაბლეტები ძაღლებისთვის
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. For 22.8-26.7 kg the label also allows half a 5.4 mg plus half a 16 mg tablet. Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
· twice daily for up to 14 days, then once daily
twice daily for up to 14 days, then once daily
GeorgiaYes, veterinary
Veterinary (National Food Agency)
In the register: აპოქუელი 5.4მგ შემოგარსული ტაბლეტები ძაღლებისთვის
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. For 22.8-26.7 kg the label also allows half a 5.4 mg plus half a 16 mg tablet. Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
· twice daily for up to 14 days, then once daily
twice daily for up to 14 days, then once daily
GeorgiaYes, veterinary
Veterinary (National Food Agency)
In the register: აპოქუელი 5.4მგ შემოგარსული ტაბლეტები ძაღლებისთვის
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. For 22.8-26.7 kg the label also allows half a 5.4 mg plus half a 16 mg tablet. Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
Dog
4.5–5.9 kg
By mouth
twice daily for up to 14 days, then once daily
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Apoquel 3.6 mg, 5.4 mg and 16 mg film-coated tablets for dogs - Summary of Product Characteristics
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. For 22.8-26.7 kg the label also allows half a 5.4 mg plus half a 16 mg tablet. Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
Dog
9–13.4 kg
By mouth
twice daily for up to 14 days, then once daily
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Apoquel 3.6 mg, 5.4 mg and 16 mg film-coated tablets for dogs - Summary of Product Characteristics
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. For 22.8-26.7 kg the label also allows half a 5.4 mg plus half a 16 mg tablet. Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
Dog
20–26.7 kg
By mouth
twice daily for up to 14 days, then once daily
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Apoquel 3.6 mg, 5.4 mg and 16 mg film-coated tablets for dogs - Summary of Product Characteristics
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. At 20.0-26.7 kg half a 16 mg tablet is combined with half a 3.6 mg (20.0-22.7 kg) or half a 5.4 mg tablet (22.8-26.7 kg). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
· twice daily for up to 14 days, then once daily
twice daily for up to 14 days, then once daily
GeorgiaYes, veterinary
Veterinary (National Food Agency)
In the register: აპოქუელი 16მგ შემოგარსული ტაბლეტები ძაღლებისთვის
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. At 20.0-26.7 kg half a 16 mg tablet is combined with half a 3.6 mg (20.0-22.7 kg) or half a 5.4 mg tablet (22.8-26.7 kg). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
· twice daily for up to 14 days, then once daily
twice daily for up to 14 days, then once daily
GeorgiaYes, veterinary
Veterinary (National Food Agency)
In the register: აპოქუელი 16მგ შემოგარსული ტაბლეტები ძაღლებისთვის
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. At 20.0-26.7 kg half a 16 mg tablet is combined with half a 3.6 mg (20.0-22.7 kg) or half a 5.4 mg tablet (22.8-26.7 kg). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
· twice daily for up to 14 days, then once daily
twice daily for up to 14 days, then once daily
GeorgiaYes, veterinary
Veterinary (National Food Agency)
In the register: აპოქუელი 16მგ შემოგარსული ტაბლეტები ძაღლებისთვის
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. At 20.0-26.7 kg half a 16 mg tablet is combined with half a 3.6 mg (20.0-22.7 kg) or half a 5.4 mg tablet (22.8-26.7 kg). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
· twice daily for up to 14 days, then once daily
twice daily for up to 14 days, then once daily
GeorgiaYes, veterinary
Veterinary (National Food Agency)
In the register: აპოქუელი 16მგ შემოგარსული ტაბლეტები ძაღლებისთვის
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. At 20.0-26.7 kg half a 16 mg tablet is combined with half a 3.6 mg (20.0-22.7 kg) or half a 5.4 mg tablet (22.8-26.7 kg). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
Dog
13.5–19.9 kg
By mouth
twice daily for up to 14 days, then once daily
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Apoquel 3.6 mg, 5.4 mg and 16 mg film-coated tablets for dogs - Summary of Product Characteristics
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. At 20.0-26.7 kg half a 16 mg tablet is combined with half a 3.6 mg (20.0-22.7 kg) or half a 5.4 mg tablet (22.8-26.7 kg). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
Dog
26.8–39.9 kg
By mouth
twice daily for up to 14 days, then once daily
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Apoquel 3.6 mg, 5.4 mg and 16 mg film-coated tablets for dogs - Summary of Product Characteristics
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. At 20.0-26.7 kg half a 16 mg tablet is combined with half a 3.6 mg (20.0-22.7 kg) or half a 5.4 mg tablet (22.8-26.7 kg). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
Dog
40–54.9 kg
By mouth
twice daily for up to 14 days, then once daily
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Apoquel 3.6 mg, 5.4 mg and 16 mg film-coated tablets for dogs - Summary of Product Characteristics
0.4-0.6 mg/kg: twice daily for up to 14 days, then the same dose once daily for maintenance, after weighing benefit against risk. At 20.0-26.7 kg half a 16 mg tablet is combined with half a 3.6 mg (20.0-22.7 kg) or half a 5.4 mg tablet (22.8-26.7 kg). Not under 12 months or 3 kg. A leftover half goes back in the blister and is used within 3 days.
Dog
55–80 kg
By mouth
twice daily for up to 14 days, then once daily
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Apoquel 3.6 mg, 5.4 mg and 16 mg film-coated tablets for dogs - Summary of Product Characteristics
Do not use oclacitinib in dogs younger than 12 months or weighing less than 3 kg.
Critical
Do not use oclacitinib in dogs with evidence of immune suppression, including hyperadrenocorticism, because it has not been evaluated in these patients.
Critical
Do not use oclacitinib in dogs with evidence of immune suppression.
Critical
Do not use oclacitinib in dogs with progressive malignant neoplasia. Lymphoma has been reported very rarely; papilloma and lipoma are more common.
Critical
Known hypersensitivity to oclacitinib or any excipient, including lactose, is a contraindication.
Warning
Oclacitinib may increase susceptibility to infection. Investigate and treat bacterial, fungal, and parasitic infection before treatment; pyoderma is very common.
Warning
Oclacitinib is not recommended during pregnancy or in dogs intended for breeding.
Warning
Oclacitinib is not recommended during lactation.
Sources: Apoquel SPC
Caution
Oclacitinib can increase susceptibility to infection and may worsen neoplastic disease. During prolonged treatment, monitor for infection and neoplasia and perform periodic complete blood counts and serum biochemistry. Do not use in dogs weighing less than 3 kg.
Related products
Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.
Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.
For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.
Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.
The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.
